# Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Pharmaceuticals. Price $11.54, market value $2.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Trulieve Cannabis Corp. Subordinate Voting Shares reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.77**. A PEG of 0.77 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.0×**. Each dollar of revenue is priced at 2.0×.
- **Price / book: 2.9×**. The shares trade at 2.9× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 8.8%** (5-yr avg 5.7%). Free cash flow equals 8.8% of the market value, above its five-year average of 5.7%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Gross margin: 59.5%**. Trulieve Cannabis Corp. Subordinate Voting Shares keeps 59.5% of revenue after the direct cost of what it sells.
- **Operating margin: -24.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -10.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -10.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -21.4%**. Return on all capital, debt included, is -21.4%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -17.7%**. Each dollar of assets produces -17.7% of profit.

## Growth
- **Revenue growth (1 yr): -0.4%** (3-yr -1.0%/yr, 5-yr 17.8%/yr). Revenue fell 0.4% over the last year, against 17.8% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 26.6%**. Earnings per share rose 26.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.12**. Debt is 0.12 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.7×**. It would take 0.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 4.43** (quick 4.43). Current assets cover the next year's liabilities 4.43 times.
- **Altman Z-score: 2.26**. A Z-score of 2.26 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Trulieve Cannabis Corp. Subordinate Voting Shares does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (7 analysts). 7 analysts cover Trulieve Cannabis Corp. Subordinate Voting Shares; the consensus is strong_buy, with an average price target of $18.18 (+58% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 53.1%** (YTD 27.7%, 3-mo 29.1%). The shares are up 53.1% over twelve months including dividends.
- **From 52-week high: -13.1%** (150.0% above the low). Trading 13% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 54**. An RSI of 54 is neutral.
- **Beta (1 yr): 1.14** (volatility 110%). Beta of 1.14 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TRLV · Page: https://foliofundamentals.com/stocks/trlv

Not investment advice.